United States: President Trump Acts To Make Changes To The Affordable Care Act

Acting on his promise, communicated in a tweet earlier this week, that "[s]ince Congress can't get its act together on HealthCare, I will be using the power of the pen to give great HealthCare to many people - FAST," President Donald Trump yesterday morning signed an executive order (EO) "Promoting Healthcare Choice and Competition Across the United States." The EO sets in motion a process intended to lift restrictions placed upon association health plans, or AHPs, by the Affordable Care Act (ACA). But he didn't stop there. In a late-night press release that same day, the White House announced that the federal government would discontinue making cost-sharing reduction payments (CSRs) to insurance companies under the ACA immediately.

The EO, in part, instructs the Labor, Treasury, and Health and Human Services (HHS) Departments to rewrite federal rules to allow more groups and individuals to participate in AHPs, which are able to offer health plans without the essential health benefits required under the ACA and do not have to base premium rates on community rating. In addition, the EO directs agencies to expand access to short term, limited duration (STLD) insurance and health reimbursement arrangements (HRAs). Interestingly, the EO begins by setting forth a policy of the executive branch "to the extent consistent with law, to facilitate the purchase of insurance across State lines," but then goes on to focus more specifically on AHPs, STLD coverage and HRAs, with no further mention of allowing purchases across state lines.

In the late night press release, the White House said that HHS, based on guidance from the Department of Justice, had "concluded that there is no appropriation for cost-sharing reduction payments to insurance companies under Obamacare, " and therefore it would no longer reimburse insurers for lowering costs for customers under the ACA. These payments, which are expected to total $7 billion this year, could likely have little immediate impact, as insurers have already filed their rates for 2018 and built in this contingency. But the elimination of CSRs is expected to have serious consequences for insurance company participation in the ACA in 2019 and beyond. 

What are AHPs?

AHPs provide an alternative way for individuals to purchase insurance beyond the traditional individual and employer marketplaces. These plans are typically offered through organizations, trade associations, or employers who share a common interest. To date, both prior to and after the passage of the ACA, state regulators and the Labor Department have required that any association that offers insurance to its members be a "bona fide" group, formed for purposes other than obtaining insurance.

Since the implementation of the ACA, AHPs have been required to cover 10 essential health benefits and are subject to the ban on preexisting condition exclusions. Under the Trump administration, there have already been attempts by Congress to deregulate AHPs, most recently in March 2017, when H.R. 1101, the "Small Business Health Fairness Act of 2017," passed in the House (236-175) but never made it to a vote in the Senate.

What does the EO mean for AHPs?

President Trump's EO aims to loosen the restrictions placed on AHPs by permitting them to be exempt from many of the restrictions created by the ACA and by permitting consumers to purchase insurance from AHPs across state lines. Because the EO directs implementation through the traditional rulemaking process, the nuances of its implications for consumers, employers, insurance carriers, regulators and other stakeholders will continue to evolve.  

What the EO, in connection with the associated White House press release, does make clear, however, is that it would broaden the definition of AHPs to permit employers to join together to offer coverage to their employees. The press release refers specifically to employers "in the same line of business" anywhere in the country; the EO is less specific, referring to common geography or industry," but notes that groupings could be for purposes of self-insurance or the purchase of "large group health insurance." Based on how the Agencies choose to implement this change, it could mark a very significant break from the longstanding state and federal requirement, described above, that associations be formed for purposes other than obtaining insurance. It is unclear through what mechanism a grouping of unrelated employers would "self-insure" and what changes to the Employee Retirement Income Security Act of 1974 (ERISA) and state law might be required to effectuate such a change. The EO refers to potential expansion of "the conditions that satisfy the commonality-of-interest requirements" with respect to the definition of "employer" at section 3(5) of ERISA.

It also remains unclear how agency actions to roll back ACA requirements relating to associations will interact with limitations on association health insurance that were in place in most states before the ACA. Federal agencies may attempt to preempt such regulations, but such an attempt would almost certainly be subject to litigation by at least some states seeking to maintain their pre-ACA restrictions.

Finally, we note that, according to the press release, the administration intends that the EO would continue to make AHPs subject to the ban on preexisting condition exclusions. It also says that AHPs would not be able to exclude any employee from such plans. Again, these details will not be final until rulemaking is final.

How soon could we expect to see changes with respect to AHPs?

The EO directs the agencies to promulgate proposed regulations on AHPs and short term limited duration insurance within 60 days and to allow for a notice and comment period. Proposed HRA regulations are required within 120 days.

We will continue to monitor agency implementation with respect to these key issues.

What is STLD insurance and how is it used?

STDL insurance is coverage that lasts less three months and that is issued in the individual market. (Recently, in October 2016, the timeframe within the definition was reduced from twelve to three months, the culmination of efforts of the Obama administration to further reduce consumer reliance on STDL products.) STDL insurance is meant to fill gaps in coverage, such as when an individual is between jobs or travelling out of the country. As a result, it is exempt from many ACA requirements, including the ban on preexisting condition exclusions and the requirement to offer essential health benefits. And when the individual mandate was enforced, it did not constitute minimum essential coverage (i.e., it is not major medical coverage). Nonetheless, STDL insurance is attractive to "young healthy" consumers and consumers without preexisting conditions who cannot afford major medical coverage. The EO directs federal agencies to consider "expanding coverage" under STDL insurance, most likely by reverting to a 12-month or longer duration and by allowing renewal at the option of the consumer (i.e., potentially adding a guaranteed renewability requirement to make the coverage more like major medical coverage).

What are the implications of these changes for individuals?

AHPs are popular with both the associations that create them and the consumers that use them, in part because they can often offer better rates and benefits that may not be available to individual consumers. Although AHPs do not have the market presence that larger insurers have, they do have more negotiating power than is available to individuals in the individual market. Presumably, lessening the restrictions that AHPs are currently subject to will enable such plans to have even more bargaining power in the marketplace, and therefore increase competition, and will potentially lower premiums for some consumers since the coverage offered by the AHPs may not include all of the currently required essential health benefits.

Conversely, expanding AHPs would likely create concerns regarding market stability. Relaxing restrictions on AHPs could compound adverse selection issues in the individual market (with more, presumably healthier, employees leaving the individual market to enroll in employer AHPs). In addition, consumers could potentially have the ability to switch back and forth between AHPs and other market pools depending on the amount of coverage desired and the cost in each.

Expanding the use of STLD products, which are significantly less expensive than individual market major medical products, would lead to adverse selection in the same way--healthier individuals without preexisting conditions would choose STLD products, leaving the state's individual market risk pool with a higher ratio of high cost individuals. On the plus side, individuals who arguably do not "need" major medical coverage, could buy more affordable coverage that better suits their needs.

What are the implications of these changes for insurers?

Health insurers have expressed mixed views regarding the deregulation of AHPs. Insurers who have expanded into the individual insurance market may face the threat that the pool of consumers which they serve may become smaller and also, more costly based upon, at least in part, AHPs pulling healthy consumers into that market instead of mainstream ACA plans.

There are, however, opportunities for insurers.

Interestingly, based on how the agencies implement the EO, we would anticipate that insurers other than traditional major medical carriers would offer STLD products. While major medical carriers do offer STLD products, other insurers typically specialize in these "excepted benefits" products which tend to be marketed and supported differently from major medical products.

Since the ACA was passed, there has been great interest from existing carriers and start-ups in creating novel insurance offerings that can "fill the gaps" as out of pocket costs for consumers grow. Any relaxing of ACA regulations will be viewed by some in the industry, and entrepreneurs outside of the industry, as a potential for innovation.

On the other hand, traditional major medical carriers, providers and consumer protection groups have vocally opposed the ACA "repeal and replace" efforts to date. This EO combined with impending tax cut proposals likely to be funded by cuts to Medicare and Medicaid, are essentially a work-around aimed at the same ends (referred to as "synthetic repeal"). Insurers have implemented ACA requirements at great cost. Stopping the enforcement of the individual mandate while continuing to require carriers to cover individuals with preexisting conditions (not to mention guaranteed renewability and availability) will almost definitely cause premiums to continue to rise. As described above, the EO may further cannibalize major medical business through increased sales of STLD and AHP products.

How will the EO impact state regulatory agencies?

Some state regulators have expressed concerns about a decrease in their ability to enforce state regulations and protect consumers if insurers are permitted to sell insurance across state lines. Additionally, if AHPs are increasingly regulated by the Department of Labor, instead of individual states, there is also concern that the Department of Labor will not have the comprehensive tools used by states to protect consumers.

Some states have questioned the legality of the EO, such as the Massachusetts Attorney General, who stated that her office "will oppose any attempt to undermine" the state's commitment to offer health insurance. However, her reaction is far from unanimous. There are many proponents for the deregulation of AHPs who argue that an increase in competition will only aid consumers in getting the coverage they need for lower premiums. 

What is the NAIC's position on the EO?

The National Association of Insurance Commissioners (NAIC) has consistently opposed the deregulation of AHPs because it believes that such an action "would fragment and destabilize the small group market, resulting in higher premiums for many small businesses." Additionally, the NAIC has expressed concerns regarding the interstate sale of insurance because this would enable insurers to choose their regulator—thus preventing regulators from being able to effectively assist the consumers within their state.

In a statement issued yesterday, Ted Nickel, NAIC President and Wisconsin Insurance Commissioner, stated:

The NAIC and its members have long-supported the goals of giving consumers broad access to quality, affordable healthcare.  We recognize the intention of today's Executive Order is to meet those objectives.  With respect to short-term duration plans, we welcome and support returning to state regulators authority and market oversight of these products.  The NAIC has long expressed concerns with expanding AHPs in a manner that reduces consumer protections or solvency requirements that promote safe and sound markets.  We also have concerns about the impact of such a proposal on already fragile markets.  We look forward to working with the Administration and DOL in their rule making process to help address these concerns.  Finally, we continue to urge the Administration to take steps in the near term to stabilize the individual market.

The elimination of CSRs

CSRs are a central pillar of the ACA. The ACA requires insurers in the individual market to provide discounts to people based on their income level. For low-income people, the insurer is required to foot most or all of the cost of coverage, with the federal government reimbursing the insurer through CSR payments. Thus, CSRs are the central mechanism for providing affordable coverage to lower-income people in the individual markets. Without CSR payments, insurers will either have to raise their rates across the board or leave the individual marketplace.

CSRs have long been subject to legal challenge based on an argument that Congress failed to make a specific appropriation for them. The Obama administration lost its defense of the CSRs in federal district court last year. That case is now on appeal, and 17 state attorneys general have intervened to defend the CSRs. The White House announcement that the administration is discontinuing CSR payments was based on a Justice Department finding siding with the challengers in the lawsuit. The announcement places new focus on that litigation and on bipartisan efforts in the Senate to revise the ACA, appropriate for CSR payments, and otherwise stabilize the health insurance markets.

Moving Forward

Dentons will be closely monitoring the evolution of the EO and its implementation, as well as the ongoing battle over CSR payments. Our innovative teams are prepared to analyze the risks and opportunities for all stakeholders. With our deep bench of former insurance regulators and attorneys general, insurance regulatory counsel, ERISA and tax teams, and health care market and public policy expertise, we are uniquely situated to help our clients leverage these developments to their best advantage.

Dentons is the world's first polycentric global law firm. A top 20 firm on the Acritas 2015 Global Elite Brand Index, the Firm is committed to challenging the status quo in delivering consistent and uncompromising quality and value in new and inventive ways. Driven to provide clients a competitive edge, and connected to the communities where its clients want to do business, Dentons knows that understanding local cultures is crucial to successfully completing a deal, resolving a dispute or solving a business challenge. Now the world's largest law firm, Dentons' global team builds agile, tailored solutions to meet the local, national and global needs of private and public clients of any size in more than 125 locations serving 50-plus countries. www.dentons.com.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Events from this Firm
22 Jan 2019, Seminar, San Francisco, United States

Dentons is pleased to offer a full day of classes, just in time for the California MCLE compliance period deadline of January 31, 2019.*

30 Jan 2019, Other, Chicago, United States

Please join us on January 30, 2019, for the Fifth Annual Courageous Counsel Leadership Institute. This year's theme is "Risk and reward: Creating a culture that promotes innovation, change and growth.

Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions